In particular, the induction of PEDF expression [80], the inhibition of the Notch signalling pathway [81] and the ablation of β-catenin [82] in CAFs were shown to suppress fibroblast activation, CAF differentiation and the CAF’s ability to promote cancer growth and progression. Here, SERPINF1 is linked to cancer.